(Q55041777)

English

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. (English)

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

phase III clinical trial

0 references

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

Everett E Vokes

14

object named as

Everett E Vokes

1 reference

Europe PubMed Central

16 June 2018

1

object named as

Fadlo R Khuri

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

17

object named as

Waun Ki Hong

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

3

object named as

Scott M Lippman

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

author name string

J Jack Lee

2

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Edward S Kim

4

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Jay S Cooper

5

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Steven E Benner

6

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Rodger Winn

7

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Thomas F Pajak

8

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Brendell Williams

9

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

George Shenouda

10

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Ian Hodson

11

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Karen Fu

12

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Dong M Shin

13

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Lei Feng

15

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Helmuth Goepfert

16

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Journal of the National Cancer Institute

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

98

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

7

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

441-450

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Adjuvant treatment of stage I lung cancer with high-dose vitamin A.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Promoter methylation of retinoic acid receptor beta 2 and the development of second primary lung cancers in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Retinoids in lung cancer: friend, foe, or fellow traveler?

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ091

21 January 2018

Identifiers

10.1093/JNCI/DJJ091

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/16595780

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55041777&oldid=2077260203"